Lenalidomid Wh (Lenalidomide)

Lenalidomide binds to cereblon, a component of the CRL4‑E3 ubiquitin ligase complex, leading to the targeted degradation of transcription factors Ikaros and Aiolos. This action modifies the immune environment, inhibits angiogenesis, and induces apoptosis and cell‑cycle arrest in malignant plasma cells, providing anti‑tumor activity in hematologic cancers.

The specific dose of Lenalidomid Wh is individualized by the treating physician based on the patient’s diagnosis, disease stage, renal function, and prior therapies. Prescribers determine the appropriate strength, schedule, and duration according to clinical guidelines and patient‑specific factors.

Lenalidomid Wh is classified as Pregnancy Category X, meaning it is contraindicated in pregnant women because it can cause fetal harm. Women of childbearing potential must use effective contraception. The drug is also not recommended for breastfeeding mothers, as it may be excreted in breast milk and affect the infant.

To order Lenalidomid Wh, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and assistance with import documentation.

Both lenalidomide and thalidomide belong to the immunomodulatory drug class, but lenalidomide is more potent, has a more favorable safety profile, and exhibits stronger anti‑angiogenic and immune‑stimulating effects. Lenalidomide is generally preferred for multiple myeloma and related disorders because it causes fewer peripheral neuropathy events than thalidomide.

Lenalidomid Wh should be stored at ambient temperature, preferably below 25 °C, in its original container to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in areas with high humidity or direct sunlight.

Lenalidomid Wh is taken orally, usually with or without food, as directed by the prescribing clinician. The tablets should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

Serious risks include venous thromboembolism, severe neutropenia or infections, secondary primary malignancies, hepatic dysfunction, and rare severe skin reactions such as Stevens‑Johnson syndrome. Patients should be monitored regularly for signs of blood clots, infections, liver enzyme elevations, and any unusual skin changes.

Lenalidomid Wh should not be used by pregnant women, individuals with known hypersensitivity to lenalidomide or its excipients, patients with severe uncontrolled infections, or those with severe neutropenia or thrombocytopenia without appropriate medical supervision. Caution is also advised in patients with significant renal or hepatic impairment.